Literature DB >> 23922376

Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.

Sheila Weinmann1, Colleen Chun, D Scott Schmid, Michelle Roberts, Meredith Vandermeer, Karen Riedlinger, Stephanie R Bialek, Mona Marin.   

Abstract

BACKGROUND: Vaccine-strain herpes zoster (HZ) can occur after varicella vaccination. This study determined the number and proportion of HZ cases caused by vaccine-strain varicella zoster virus (VZV), assessed the positive predictive value of provider diagnosis of HZ, and computed HZ incidence rates in vaccinated and unvaccinated children.
METHODS: We used electronic medical records to identify all office visits with an HZ diagnosis for children aged <18 years in a managed care plan. Providers collected skin specimens and completed a questionnaire. Specimens were tested by polymerase chain reaction to identify wild-type or vaccine-strain VZV.
RESULTS: From May 2005 to September 2009, we enrolled 322 subjects. VZV was detected in 82% of specimens (84% wild-type, 15% vaccine-strain, 1% possible vaccine-wild-type recombinant). Among the 118 vaccinated subjects, VZV was detected in 70% (52% wild-type). The positive predictive value for provider diagnosis of "definite HZ" was 93% for unvaccinated and 79% for vaccinated children. The incidence of laboratory-confirmed HZ was 48 per 100,000 person-years in vaccinated children (both wild-type and vaccine-strain) and 230 per 100,000 person-years in unvaccinated children (wild-type only).
CONCLUSIONS: HZ incidence in vaccinated children was 79% lower than in unvaccinated children. Among vaccinated children, half of HZ cases were due to wild-type VZV.

Entities:  

Keywords:  children; epidemiology; herpes zoster; incidence; shingles; varicella vaccine; varicella zoster virus

Mesh:

Substances:

Year:  2013        PMID: 23922376     DOI: 10.1093/infdis/jit405

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  55 in total

1.  A Toddler With Rash, Encephalopathy, and Hemolytic Anemia.

Authors:  Christiana Smith; Cullen Dutmer; D Scott Schmid; Megan K Dishop; William J Bellini; Erwin W Gelfand; Edwin J Asturias
Journal:  J Pediatric Infect Dis Soc       Date:  2015-05-28       Impact factor: 3.164

2.  Impact of vaccination on the epidemiology of varicella.

Authors:  Roger Baxter
Journal:  Transl Pediatr       Date:  2015-01

3.  Fifteen years of routine childhood varicella vaccination in the United States-strong decrease in the burden of varicella disease and no negative effects on the population level thus far.

Authors:  Andrea Streng; Johannes G Liese
Journal:  Transl Pediatr       Date:  2014-10

4.  Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013.

Authors:  Erica D Dommasch; Cara J Joyce; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

5.  Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.

Authors:  Christiane S Eberhardt; Andreas Wieland; Tahseen H Nasti; Alba Grifoni; Elizabeth Wilson; D Scott Schmid; Bali Pulendran; Alessandro Sette; Edmund K Waller; Nadine Rouphael; Rafi Ahmed
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 6.  Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.

Authors:  Giovanni Gabutti; Paolo Bonanni; Michele Conversano; Guido Fanelli; Elisabetta Franco; Donato Greco; Giancarlo Icardi; Marzia Lazzari; Alessandro Rossi; Silvestro Scotti; Antonio Volpi
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

7.  THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

Review 8.  Varicella Virus Vaccination in the United States.

Authors:  Jana Shaw; Anne A Gershon
Journal:  Viral Immunol       Date:  2017-11-27       Impact factor: 2.257

9.  Varicella Zoster Virus and Giant Cell Arteritis.

Authors:  Anne A Gershon; Michael Gershon
Journal:  J Infect Dis       Date:  2016-03-31       Impact factor: 5.226

10.  Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.

Authors:  Dana Perella; Chengbin Wang; Rachel Civen; Kendra Viner; Karen Kuguru; Irini Daskalaki; D Scott Schmid; Adriana S Lopez; Hung Fu Tseng; E Claire Newbern; Laurene Mascola; Stephanie R Bialek
Journal:  Pediatrics       Date:  2016-03-14       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.